Erectile Dysfunction Drugs Market is Expected to Reach USD 5.65 billion by 2032, Growing at an Astonishing 7.9% CAGR | Key Players- S.K. Chemicals Co. Ltd, Dong-A Pharmaceutical Co. Ltd, Meda Pharmaceuticals

𝐀𝐜𝐜𝐨𝐫𝐝𝐢𝐧𝐠 𝐭𝐨 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡'𝐬 𝐬𝐭𝐮𝐝𝐲, 𝐭𝐡𝐞 𝐄𝐫𝐞𝐜𝐭𝐢𝐥𝐞 𝐃𝐲𝐬𝐟𝐮𝐧𝐜𝐭𝐢𝐨𝐧 𝐃𝐫𝐮𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐢𝐬 𝐞𝐱𝐩𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐠𝐫𝐨𝐰 𝐚𝐭 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟕.𝟗% 𝐨𝐯𝐞𝐫 𝐭𝐡𝐞 𝐞𝐬𝐭𝐢𝐦𝐚𝐭𝐞𝐝 𝐩𝐞𝐫𝐢𝐨𝐝. 𝐓𝐡𝐞 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐯𝐚𝐥𝐮𝐞 𝐢𝐬 𝐞𝐱𝐩𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐠𝐫𝐨𝐰 𝐟𝐫𝐨𝐦 𝐔𝐒𝐃 𝟐.𝟖𝟓 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟑 𝐭𝐨 𝐔𝐒𝐃 𝟓.𝟔𝟓 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟑𝟐.

The industry's growth is being fuelled by the growing geriatric population and excessive degrees of detrimental illnesses such as diabetes, kidney failures, hypertension, hormonal imbalance, and neurological illnesses. Also, the market for erectile dysfunction drugs is expanding due to the growing consciousness of patients about erectile dysfunction and the obtainability of the cure.

𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰

About half of the men aged 40 to 70 have erectile dysfunction to some extent, albeit only 1 in 10 reveal a downright incapacity to have assemblys. Consuming an ED drug generates an assemblys adequate to commence intercourse in roughly 70% of in other respects fit men. Sildenafil is frequently the initial drug the doctor provides. It has been on the market prolonged, and its ramifications and the medicines and food it interrelates with are well acknowledged. Additionally other ED drugs obtainable in the U.S. involve avanafil (Stendra), tadalafil, and vardenafil (Levitra). These all enhance the blood supply to the penes .

𝐅𝐨𝐫 𝐌𝐨𝐫𝐞 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐨𝐧 𝐭𝐡𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭, 𝐆𝐞𝐭 𝐀 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.polarismarketresearch.com/industry-analysis/erectile-dysfunction-drugs-market/request-for-sample

𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐏𝐫𝐨𝐟𝐢𝐥𝐞

Prominent players are acquiring procedures such as mergers and acquisitions for regional augmentation to seize a larger market share. Major companies in the erectile dysfunction drugs market are noted below:
• Bayer AG
• Pfizer
• Eli Lilly & Co.
• Vivus Inc.
• S.K. Chemicals Co. Ltd.
• Dong-A Pharmaceutical Co. Ltd
• Meda Pharmaceuticals
• Apricus Biosciences
• Vivus Inc.

𝐂𝐥𝐢𝐜𝐤 𝐨𝐧 𝐭𝐡𝐞 𝐁𝐞𝐥𝐨𝐰 𝐋𝐢𝐧𝐤 𝐭𝐨 𝐁𝐮𝐲 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.polarismarketresearch.com/buy/49/2

𝐆𝐫𝐨𝐰𝐭𝐡 𝐃𝐫𝐢𝐯𝐞𝐫𝐬

• Increasing Prevalence of Erectile Dysfunction: The rising incidence of erectile dysfunction due to aging populations, lifestyle factors, and chronic health conditions such as diabetes and cardiovascular diseases is driving the demand for ED drugs.
• Advancements in Drug Formulations: Continuous innovations in drug formulations, including fast-acting oral medications, topical creams, and long-acting injectables, are enhancing treatment efficacy and patient compliance.
• Growing Awareness and Acceptance: Increased awareness about erectile dysfunction and its treatment options, coupled with the growing acceptance of discussing sexual health issues, is boosting market growth.
• Rising Disposable Income: Increasing disposable incomes, especially in developing countries, are enabling more individuals to afford ED medications.

𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐎𝐮𝐭𝐥𝐨𝐨𝐤

• North America (U.S., Canada)
• Europe (Germany, UK, France, Italy, Spain, Belgium, Russia, Netherlands)
• Asia-Pacific (China, Japan, India, Australia, Korea, Singapore, Malaysia, Indonesia, Thailand, Philippines)
• Latin America (Brazil, Mexico, Argentina)
• Middle East and Africa (UAE, Saudi Arabia

𝐁𝐫𝐨𝐰𝐬𝐞 𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭 𝐂𝐥𝐢𝐜𝐤 𝐇𝐞𝐫𝐞: https://www.polarismarketresearch.com/industry-analysis/erectile-dysfunction-drugs-market

𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐬 𝐂𝐨𝐯𝐞𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭

The research shows that erectile dysfunction drugs market analysis is primarily segmented by product, component type, dosage form, end user, and geography. According to component type, the Phosphodiesterase - 5 Inhibitors drugs are broadly advised drugs to cure erectile dysfunction and thus account prominent share in the market.
Furthermore, according to dosage form, the oral segment for the highest share. The injections are injected into the penes, which creates muscle composure of the penesand motivates blood flow into the penes.

𝐁𝐲 𝐏𝐫𝐨𝐝𝐮𝐜𝐭
• Sildenafil citrate
• Levitra/Staxyn (vardenafil)
• Stendra/Spedra (avanafil)
• Zydena (udenafil)
• Vitaros (Alprostadil Cream)
• Others

𝐁𝐲 𝐂𝐨𝐦𝐩𝐨𝐧𝐞𝐧𝐭 𝐓𝐲𝐩𝐞
• Testosterone
• Phosphodiestarse - 5 Inhibitors (PDE5I)
• Alprostadil
• others

𝐁𝐲 𝐃𝐨𝐬𝐚𝐠𝐞 𝐅𝐨𝐫𝐦
• Topical Dose
• Oral Dose
• Injection
• others

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐖𝐢𝐝𝐞-𝐫𝐚𝐧𝐠𝐢𝐧𝐠 𝐂𝐨𝐯𝐞𝐫𝐚𝐠𝐞 𝐨𝐟 𝐏𝐌𝐑'𝐬 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞:

Vitamin K2 Market: https://www.polarismarketresearch.com/industry-analysis/vitamin-k2-market

Dried Blood Spot Collection Cards Market: https://www.polarismarketresearch.com/industry-analysis/dried-blood-spot-collection-cards-market

Spirometer Market: https://www.polarismarketresearch.com/industry-analysis/spirometer-market

Viral Vector Manufaturing Market: https://www.polarismarketresearch.com/industry-analysis/viral-vector-manufacturing-market

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬:

Polaris Market Research
Phone: +1-929-297-9727
Email: sales@polarismarketresearch.com

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.